|Clinical Science: Special Reports - I|
Jay H. Traverse, MD, FAHA
Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis, Minn.
Results From LateTIME: A Randomized, Placebo Controlled Trial of Intracoronary Stem Cell Delivery Two to Three Weeks Following Acute Myocardial Infarction
Discussant: Thomas Eschenhagen, MD, Hamburg, Germany
Andreas M. Zeiher, MD
J. W. Goethe University,
|CELLWAVE Trial |
Cardiac Extracorporal Shock Wave Application to Enhance the Efficiency of Intracoronary Cell Therapy in Chronic Heart Failure - Results of the Randomized, Double-Blind, Placebo-Controlled CELLWAVE Trial
Discussant: Hina Chaudhry, MD, New York, N.Y.
|Clinical Science: Special Reports - II|
Todd McAllister, PhD
Cytograft/St. Joseph's Translational Res Institute,
|First Human Use of an Allogeneic Tissue Engineered Vascular Graft Discussant of First Human Use of an Allogeneic Tissue Engineered Vascular Graft |
Discussant: Frank W. Sellke, MD, FAHA, Providence, R.I.
David Leistner, MD
Birgit Assmus, University Hospital of Frankfurt, Frankfurt am Main, Germany
Intracoronary Infusion of Bone Marrow-Derived Mononuclear Cells in Acute Myocardial Infarction: 5 Year Clinical Outcome and MRI Data of the Randomized, Double-Blind, Placebo-Controlled REPAIR-AMI Trial
Discussant: Robert O. Bonow, MD, FAHA, Chicago, Ill.